Rare Disease Market Access and Orphan Drug Commercialization

2014 Speaking Faculty

David Brumley, MD MBA
Senior Medical Director
Tufts Health Plan

Karen Fardig, JD
Vice President, Legal
Head Counsel, Gaucher and Fabry
Shire

Gregory Gorgas, MBA
Senior Vice President, Commercial
Mast Therapeutics, Inc.

Usman Iqbal
Senior Medical Affairs Leader, Neuroscience, Global Medical Affairs
AstraZeneca

David Lemus
Chief Executive Officer,
Sigma-Tau Pharmaceuticals
Board, PhRMA
Board, BioHealth Innovation
Chairperson,
Proteros biostructures GmbH
Board, MediGene AG
Board, Axela

Jeff Myers, MBA
President
Medicaid Health Plans of America

Stephanie Okey, MS
Head, North America, Rare Diseases
Senior Vice President, U.S. General Manager
Genzyme Corporation

John Tagliamonte, MBA
Chief Business Officer, Oxyrane
Advisory Board, Cocoon Biotech

Stephan Toutain, MS, MBA
Global Commercial Development
Sarepta Therapeutics

Home :: Health Care :: Legal & IP :: Pharmaceutical :: Live Stream

Opportunities :: Compendium Products :: News :: Videos :: About :: Site Map :: Privacy

© 2015 World Congress | 500 West Cummings Park, Suite 5400 | Woburn, MA 01801 | 800-767-9499